 Home > Medical News > Medical Research Articles > Genting Xinyao is licensed to globally develop and commercialize the 3CL protease inhibitor from the Singapore Experimental Drug Research and Development Center, which is expected to become a class-leading oral anti-COVID-19 drug

Genting Xinyao is licensed to globally develop and commercialize the 3CL protease inhibitor from the Singapore Experimental Drug Research and Development Center, which is expected to become a class-leading oral anti-COVID-19 drug

 Last Update: 2022-01-23
 Source: Internet
 Author: User

Tags

humira drug class

lyrica drug schedule

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Under the terms of the agreement, Genting Sunyao will receive an exclusive worldwide license to a group of 3CL protease inhibitors developed by EDDC, which have also been shown to be effective against 2019-nCoV and its variants, as well as other coronaviruses, such as the coronavirus that causes Middle East Respiratory Syndrome.

The candidate drug EDDC-2214 is a novel and potent 3CL protease inhibitor against 2019-nCoV, which is being developed as an oral anti-2019-nCoV drug

Dr.

EDDC aims to develop therapeutics and diagnostics to save and improve the lives of patients in Singapore, Asia and other parts of the world

Professor Damian O'Connell, MD, Chief Executive Officer of EDDC, said: "This agreement with EDDC allows us to fully realize the potential of EDDC-2214 for the benefit of patients around the world

Under the terms of the transaction, EDDC will receive an initial down payment , subsequent clinical and commercial milestone payments and specific royalties on net product sales

Genting Sunyao is committed to ensuring the global accessibility and affordability of all its COVID-19 medicines

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure 99% Mecobalamin powder CAS 13422-55-4 Vitamin B12 Methylcobalamin

CAS No.: 13422-55-4

Pharmacy Grade

$2.8-3.2/G FOB

Most professional factory supply good price with best service Ethyl 3-amino-4-(2-phthalimidoethoxy)crotonate

CAS No.: 265136-65-0

Pharmacy Grade

$1.1-1.2/MT FOB

GMP Pharmacy Grade Tirzepatide 10 mg 10 vial pack from China factory Trizep in stock Lyophilized powder

CAS No.: 2023788-19-2

Pharmacy Grade

$50.00/UNIT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.